The challenges of checkpoint inhibition in the treatment of multiple myeloma.
The challenges of checkpoint inhibition in the treatment of multiple myeloma.
复制标题
DOI:
10.1016/j.cellimm.2018.10.003
复制
发表时间:
2018-12
影响因子:
4.3
通讯作者:
Kang Y
中科院分区:
文献类型:
--
作者:
Paul B;Kang S;Zheng Z;Kang Y
Despite significant improvements in the overall survival of patients with multiple myeloma (MM) over the past 15 years, the disease remains incurable. Treatment options are limited for patients who have relapsed or are refractory to immunomodulatory drugs (IMiDs), proteasome inhibitors, and monoclonal antibodies. In these patients, immunotherapies such as checkpoint inhibitors, oncolytic vaccines, and chimeric antigen receptor (CAR) T cells provide a potentially effective alternative treatment. While checkpoint inhibitors are effective in prolonging overall survival in some patients with advanced solid cancers and Hodgkin lymphoma, they have not demonstrated significant anti-myeloma activities as a single agent in MM. In fact the combination of checkpoint inhibitors with IMiDs was recently found to increase the risk of death in myeloma patients. These challenges highlight the need for a better understanding of immune dysregulation in myeloma patients, and the mechanisms of action of- and resistance to- checkpoint inhibitors. In this review, we summarize immune dysfunction in patients with MM, and review the preclinical and clinical data regarding checkpoint inhibitors in myeloma. We conclude by proposing strategies to improve the efficacy and safety of checkpoint inhibitors in this population.
登录
查看更多内容
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
20.3
作者:
Badros, Ashraf;Hyjek, Elizabeth;Singh, Zeba
通讯作者:
Singh, Zeba
影响因子:
4.9
作者:
Boutsikou E;Domvri K;Hardavella G;Tsiouda D;Zarogoulidis K;Kontakiotis T
通讯作者:
Kontakiotis T
影响因子:
20.3
作者:
An, Gang;Acharya, Chirag;Anderson, Kenneth C.
通讯作者:
Anderson, Kenneth C.
影响因子:
11.5
作者:
Berger, Raanan;Rotem-Yehudar, Rinat;Nagler, Arnon
通讯作者:
Nagler, Arnon